Growth Metrics

Medpace Holdings (MEDP) Gross Profit (2016 - 2026)

Medpace Holdings filings provide 12 years of Gross Profit readings, the most recent being $196.3 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 10.08% to $196.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $778.6 million, a 14.58% increase, with the full-year FY2025 number at $760.6 million, up 15.89% from a year prior.
  • Gross Profit hit $196.3 million in Q1 2026 for Medpace Holdings, down from $205.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $205.3 million in Q4 2025 to a low of $98.7 million in Q1 2022.
  • Median Gross Profit over the past 5 years was $153.8 million (2024), compared with a mean of $151.2 million.
  • Biggest five-year swings in Gross Profit: skyrocketed 36.67% in 2022 and later rose 10.08% in 2026.
  • Medpace Holdings' Gross Profit stood at $115.7 million in 2022, then grew by 18.21% to $136.8 million in 2023, then skyrocketed by 30.34% to $178.3 million in 2024, then rose by 15.14% to $205.3 million in 2025, then fell by 4.38% to $196.3 million in 2026.
  • The last three reported values for Gross Profit were $196.3 million (Q1 2026), $205.3 million (Q4 2025), and $196.9 million (Q3 2025) per Business Quant data.